Skip to main content
Account

Peer review reports

From: A phase Ib/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer

Original Submission
26 Oct 2022 Submitted Original manuscript
24 Jan 2023 Reviewed Reviewer Report - Philip Bonomi
6 Apr 2023 Reviewed Reviewer Report - Ralph Zinner
9 Jun 2023 Author responded Author comments - Ernest Nadal
Resubmission - Version 2
9 Jun 2023 Submitted Manuscript version 2
12 Jun 2023 Author responded Author comments - Ernest Nadal
Resubmission - Version 3
12 Jun 2023 Submitted Manuscript version 3
13 Jun 2023 Author responded Author comments - Ernest Nadal
Resubmission - Version 4
13 Jun 2023 Submitted Manuscript version 4
26 Jun 2023 Reviewed Reviewer Report - Philip Bonomi
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
5 Jul 2023 Editorially accepted
28 Jul 2023 Article published 10.1186/s12885-023-11153-1

Learn about peer review

Back to article page

Navigation